Analyst still works today; but is your LC-MS software ready for tomorrow’s regulated environment?

Analyst software has long been a trusted foundation in regulated LC-MS laboratories—and for many, it still performs reliably today. But regulated environments are evolving faster than ever. As labs transition to Windows 11, strengthen cybersecurity policies, modernize IT infrastructure, and prepare for future compliance expectations, software decisions are no longer just about what works today—they’re about managing tomorrow’s risk. Analyst will not be supported on Windows 11. While some labs may continue operating in unsupported environments temporarily, the bigger question is: when that risk becomes reality, will your lab be reacting under pressure—or executing a planned mitigation strategy with confidence?

Why LC-MS software is no longer “Just IT” in regulated environment

For many regulated laboratories, LC-MS software decisions have historically been treated as background infrastructure. Instruments matter. Methods matter. Validation matters. Software? Often assumed to be “good enough” as long as data can be acquired and processed in a compliant manner.

That assumption no longer holds.

Across regulated laboratories, teams are being asked to do more with fewer experts, tighter timelines, and higher scrutiny—without increasing risk. In that environment, software is no longer just a tool for acquisition. It has become a primary driver of productivity, consistency, and long-term compliance sustainability.

The hidden bottleneck in modern labs

Most labs today are not limited by instrument sensitivity or scan speed: they are limited by how workflows go through the lab.

Common symptoms include:

• Experienced scientists acting as gatekeepers for routine tasks

• Heavy reliance on SOPs to control user behavior

• Manual checks layered on top of software processes

• Variability in execution across analysts running “the same” method

These issues don’t show up as instrument downtime. They show up as:

• Longer turnaround times

• Increased rework

• Audit anxiety

• Slower onboarding of new staff

At the center of all of this is software—specifically, how much the software itself guides, constrains, or relies on the user.

Why “validated” does not always mean “optimized”

In regulated environments, stability is rightly valued. Validated systems protect data integrity and patient safety. But over time, many labs confuse validated with optimized.

A workflow can be validated and still:

• Depend heavily on user expertise

• Require extensive procedural controls

• Break down when experienced staff leave

• Scale poorly as sample volume increases

When this happens, the lab compensates by adding:

• More SOP steps or additional CAPAs

• More training time

• More reviews or more scrutiny during review

• Increased dependence on tribal knowledge

All of these add operational friction. None of them improve scientific output.

The shift from expert-driven to system-driven labs

One of the most significant changes in regulated laboratories over the last decade is the availability of expertise.

Many labs are experiencing:

• Retirement or reassignment of senior “power users”

• Higher turnover rates among laboratory staff, increasing training needs

• Faster hiring cycles with less time for deep apprenticeship

• Greater reliance on generalists rather than specialists

In this reality, software can no longer assume an expert user at every step. Instead, it must embed best practices, reduce decision fatigue, and enforce consistency by design.

This is not about “dumbing down” science. It is about ensuring that routine execution does not depend on heroic expertise.

Software as a compliance strategy—not a risk

Traditionally, software change has been viewed as a regulatory risk. Increasingly, forward-looking organizations are seeing the opposite: software modernization as a way to reduce long-term compliance burden.

Modern software platforms can:

• Reduce variability in execution

• Minimize reliance on procedural controls due to experienced failures in your environment (users still need some procedural control guidance)

• Improve traceability and repeatability

• Simplify training documentation

Over time, this leads to fewer deviations, fewer corrective actions, and more predictable audits.

What does this mean for lab leadership

For leaders, the question is no longer:

“Does our software work?”

It is:

“Does our software scale, sustain, and protect us five years from now?”

Software decisions now affect:

• Staff productivity and retention

• Audit readiness

• Method lifecycle management

• Long-term operational cost

In other words, LC-MS software has become a strategic lab decision, not an IT afterthought.

 

Why Analyst still works—and why that doesn’t mean it’s the future

Any serious discussion about LC-MS software modernization must start with an honest acknowledgment: Analyst software has earned its place in a regulated environment, and for decades it has been the backbone of validated LC-MS workflows. Many labs have built robust processes, training programs, and compliance frameworks around those validated workflows—and for good reason.

Recognizing what Analyst software does well is not a concession. It is a prerequisite for making smart, risk-based decisions about what comes next.

Why Analyst became the standard

Analyst succeeded because it delivered what regulated labs needed at the time:

• Stability

• Predictability

• Deep control for expert users

• Compatibility with long-running validated methods

In environments where workflows were executed by a small number of highly experienced scientists, Analyst enabled flexibility and precision.

For many labs, it still does.

Where Analyst continues to perform exceptionally well

Analyst remains a strong choice for:

• Mature, stable workflows with no increase in throughput requirements per system

• Environments with low staff turnover

• Methods that have been validated and executed unchanged for years

• Teams with deep institutional knowledge

In these scenarios, the cost of change may outweigh the benefit. Maintaining Analyst is often the right decision.

The difference between “working” and “sustaining”

However, the fact that Analyst works does not mean it is optimized for today’s lab realities.

Many organizations are discovering that:

• New hires take significantly longer to reach independence

• SOPs have grown increasingly complex to compensate for software flexibility or limitations

• Execution quality depends heavily on who is setting up the assay

• None of these are failures of Analyst software. They are consequences of how and when it was designed.

Legacy software and the burden of expertise

Analyst assumes a knowledgeable user. In the past, that was a safe assumption. Today, it is often a liability and thus becomes a poor long-term strategy.

When software relies on expertise:

• Training becomes longer and more expensive

• Errors become harder to predict

• Compliance depends on behavior rather than system design

Over time, labs compensate with more controls—reviews, checklists, shadow SOPs (or varying SOP interpretations exist). These controls protect compliance but slow execution.

Why legacy does not mean obsolete—but it does mean limited

Calling Analyst “legacy” is not a judgment of quality. It is a statement of design era, which focused on:

• Building for expert-centric operation

• Prioritized flexibility over standardization

• Assume stable staffing models

Modern labs need systems that:

• Support consistency across users

• Reduce cognitive load

• Scale without proportional increases in oversight

• Protect what needs protecting (method and/or data locking)

This gap is what drives the need for a new software model.

The real risk of unnecessary change

It is important to say this clearly: not every workflow needs to be migrated.

For some assays, staying on Analyst is the lowest-risk, highest-confidence choice. Forced modernization introduces:

• Validation overhead

• Disruption to throughput

• Unnecessary audit exposure

Smart labs distinguish between workflows that must remain stable and workflows that can evolve.

 Key Takeaways

• LC-MS software is no longer just IT infrastructure—it is a strategic component of productivity, consistency, and long-term compliance.

• Analyst software continues to provide a reliable foundation for many validated workflows and remains the right choice for stable, mature assays.
• However, validated does not always mean optimized. As laboratories evolve, reliance on user expertise, manual reviews, and increasingly complex SOPs can create hidden operational challenges.
• A risk-based modernization strategy allows laboratories to protect validated workflows while adopting modern software capabilities for new methods, growing teams, and future business needs.

 

Call to Action

Evaluate one of your routine LC-MS workflows and ask:

• How many steps rely on analyst expertise rather than software-guided execution?
• Are additional SOPs and manual reviews compensating for software limitations?
• Which workflows truly benefit from remaining on Analyst, and which could gain efficiency, consistency, and scalability from a modern platform?

The objective is not to replace what works—it is to ensure your software strategy continues to support your laboratory as regulatory expectations; staffing models, and operational needs continue to evolve.

If you need more information, click here  to contact our team.

 

Resources:

Analyst end-of-support resource center